| Xu, Dazhi |
NCT03941561: S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC） |
|
|
| Recruiting | 3 | 1006 | RoW | S-1 for 9 months, Tegafur,Gimeracil and Oteracil Porassium Capsules, S-1 for 1 year | Fudan University | Gastric Cancer | 01/22 | 05/27 | | |
NCT03399253: Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor |
|
|
| Recruiting | 3 | 120 | RoW | surgery, chemotherapy, XELOX | Sun Yat-sen University | Gastric Cancer | 11/22 | 12/25 | | |
NCT03399110: XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC) |
|
|
| Active, not recruiting | 3 | 1032 | RoW | Oxaliplatin, Eloxatin, Capecitabine, Xeloda | Fudan University | Gastric Cancer | 08/26 | 08/26 | | |
NCT06313567: Metronomic Capecitabine in Stage III Gastric Cancer |
|
|
| Recruiting | 3 | 722 | RoW | Metronomic capecitabine group, Observation | Fudan University | Gastric Cancer | 03/29 | 03/29 | | |
NCT05246982: HLX07+HLX10+Chemotherapy or HLX07 Monotherapy in Patients With Advanced Metastatic Gastric Cancer |
|
|
| Recruiting | 2 | 40 | RoW | HLX07+HLX10+oxaliplatin+capecitabine, HLX07 | Shanghai Henlius Biotech | Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ) | 12/23 | 03/24 | | |
Miracle-G, NCT06121700: Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer |
|
|
| Recruiting | 2 | 55 | RoW | Radiotherapy targeted to the primary lesion, Radiotherapy targeted to the metastatic lesions, Anti-PD-1 monoclonal antibody, Trastuzumab, Herceptin®, Chemotherapy, R0 total/subtotal gastrectomy with D2 lymphadenectomy, Metastasectomy, Local ablative therapies | Fudan University | Adenocarcinoma, Stomach Neoplasm, Gastroesophageal-junction Cancer, Oligometastatic Disease, Metastatic Cancer, Metastatic Gastric Cancer, Adenocarcinoma of the Stomach, Gastroesophageal Junction Adenocarcinoma, Metastatic Adenocarcinoma | 12/25 | 12/27 | | |
NCT05975749: Adjuvant Serplulimab and Trastuzuma and Chemotherapy in Her-2+ Gastric Cancer |
|
|
| Recruiting | 2 | 114 | RoW | Serplulimab, Trastuzuma, Chemotherapy | Fudan University | Gastric Cancer | 01/26 | 01/29 | | |
EBPS, NCT04809025: Comparation of Endoscopic Biopsy and Postoperative Specimen for the Molecular Diagnosis of Gastric Cancer |
|
|
| Recruiting | N/A | 510 | RoW | endoscopy, Surgery | Fudan University | Stomach Neoplasms, Endoscopy, Biopsy, Pathology | 04/23 | 04/24 | | |
NCT06232395: Early Detection and Post-operative Monitoring of Gastric Cancer |
|
|
| Recruiting | N/A | 1197 | RoW | DNA test | SUZHOU HUHU HEALTH & TECHNOLOGY Inc.,, Fudan University | Gastric Cancer | 02/26 | 02/26 | | |
Dressing, NCT06263205: Wound Management Following Gl Tumor Surgery: Comparing Outcomes of Changes Versus Non- Techniques |
|
|
| Not yet recruiting | N/A | 816 | RoW | Non-Dressing of Surgical Wound, Regular Dressing Change of Surgical Wound | Fudan University, Shanghai Changzheng Hospital, Changhai Hospital, Shanghai East Hospital | Gastrointestinal Tumors, Surgical Wound Infection, Pain, Postoperative | 01/26 | 12/26 | | |
NCT06468969: Enhanced vs. Routine Follow-Up After Total Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial |
|
|
| Not yet recruiting | N/A | 158 | NA | Enhanced Follow-up | Fudan University | Gastric Cancer, Total Gastrectomy, Postoperative Care, Quality of Life, Follow-up | 07/26 | 07/29 | | |
NCT05541783: Laparoscopic-assisted Distal Gastrectomy and Totally Laparoscopic Distal Gastrectomy for Gastric Cancer |
|
|
| Recruiting | N/A | 202 | RoW | laparoscopy-assisted distal gastrectomy Group, Totally laparoscopic distal gastrectomy | Fudan University | Gastric Cancer | 09/24 | 09/25 | | |
NCT05537129: Laparoscopic vs Open Total Gastrectomy for Gastric Cancer |
|
|
| Recruiting | N/A | 600 | RoW | Total Gastrectomy | Fudan University | Gastric Cancer | 10/24 | 10/27 | | |
